ID   NEUR4_HUMAN             Reviewed;         484 AA.
AC   Q8WWR8; A8K056; J3KNJ5; Q96D64;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   10-MAY-2017, entry version 136.
DE   RecName: Full=Sialidase-4;
DE            EC=3.2.1.18;
DE   AltName: Full=N-acetyl-alpha-neuraminidase 4;
GN   Name=NEU4; ORFNames=LP5125;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND VARIANT ARG-301.
RC   TISSUE=Fibroblast;
RX   PubMed=14962670; DOI=10.1016/j.ygeno.2003.08.019;
RA   Monti E., Bassi M.T., Bresciani R., Civini S., Croci G.L., Papini N.,
RA   Riboni M., Zanchetti G., Ballabio A., Preti A., Tettamanti G.,
RA   Venerando B., Borsani G.;
RT   "Molecular cloning and characterization of NEU4, the fourth member of
RT   the human sialidase gene family.";
RL   Genomics 83:445-453(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-301.
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-301.
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Oligodendroglioma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, ALTERNATIVE SPLICING
RP   (ISOFORM 2), CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND
RP   GLYCOSYLATION.
RX   PubMed=15213228; DOI=10.1074/jbc.M404531200;
RA   Seyrantepe V., Landry K., Trudel S., Hassan J.A., Morales C.R.,
RA   Pshezhetsky A.V.;
RT   "Neu4, a novel human lysosomal lumen sialidase, confers normal
RT   phenotype to sialidosis and galactosialidosis cells.";
RL   J. Biol. Chem. 279:37021-37029(2004).
RN   [8]
RP   INDUCTION.
RX   PubMed=15885103; DOI=10.1111/j.1742-4658.2005.04679.x;
RA   Stamatos N.M., Liang F., Nan X., Landry K., Cross A.S., Wang L.X.,
RA   Pshezhetsky A.V.;
RT   "Differential expression of endogenous sialidases of human monocytes
RT   during cellular differentiation into macrophages.";
RL   FEBS J. 272:2545-2556(2005).
CC   -!- FUNCTION: May function in lysosomal catabolism of sialylated
CC       glycoconjugates. Has sialidase activity towards synthetic
CC       substrates, such as 2'-(4-methylumbelliferyl)-alpha-D-N-
CC       acetylneuraminic acid (4-MU-NANA or 4MU-NeuAc). Has a broad
CC       substrate specificity being active on glycoproteins,
CC       oligosaccharides and sialylated glycolipids.
CC       {ECO:0000269|PubMed:14962670, ECO:0000269|PubMed:15213228}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of alpha-(2->3)-, alpha-(2->6)-,
CC       alpha-(2->8)- glycosidic linkages of terminal sialic acid residues
CC       in oligosaccharides, glycoproteins, glycolipids, colominic acid
CC       and synthetic substrates. {ECO:0000269|PubMed:15213228}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 3.2.;
CC   -!- INTERACTION:
CC       P63010:AP2B1; NbExp=3; IntAct=EBI-10277551, EBI-432924;
CC       Q99750:MDFI; NbExp=4; IntAct=EBI-746964, EBI-724076;
CC       O15162:PLSCR1; NbExp=2; IntAct=EBI-746964, EBI-740019;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-10277551, EBI-533224;
CC       Q15654:TRIP6; NbExp=3; IntAct=EBI-10277551, EBI-742327;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Membrane; Peripheral membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Lysosome lumen. Note=According to
CC       PubMed:15213228, isoform 2 is soluble, N-glycosylated and found in
CC       the lumen of lysosomes. However, no signal sequence nor N-
CC       glycosylation site is predicted from the sequence.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8WWR8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WWR8-2; Sequence=VSP_037491;
CC       Name=3;
CC         IsoId=Q8WWR8-3; Sequence=VSP_047123;
CC         Note=Gene prediction based on EST data.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous with higher expression in heart,
CC       skeletal muscle, liver and placenta.
CC       {ECO:0000269|PubMed:14962670}.
CC   -!- INDUCTION: Down-regulated during monocyte to macrophage
CC       differentiation. {ECO:0000269|PubMed:15885103}.
CC   -!- PTM: According to PubMed:15213228, phosphorylation of mannose
CC       residues may ensure efficient transport of isoform 2 to the
CC       lysosomes via the mannose 6-phosphate receptor.
CC   -!- PTM: Isoform 2 is glycosylated. {ECO:0000269|PubMed:15213228}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 33 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAP34475.1; Type=Frameshift; Positions=291; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ277883; CAC81904.1; -; mRNA.
DR   EMBL; AK289421; BAF82110.1; -; mRNA.
DR   EMBL; AY203952; AAP34475.1; ALT_FRAME; mRNA.
DR   EMBL; AC114730; AAX82022.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW71296.1; -; Genomic_DNA.
DR   EMBL; BC012899; AAH12899.2; -; mRNA.
DR   CCDS; CCDS2553.1; -. [Q8WWR8-2]
DR   CCDS; CCDS54441.1; -. [Q8WWR8-3]
DR   CCDS; CCDS54442.1; -. [Q8WWR8-1]
DR   RefSeq; NP_001161071.1; NM_001167599.2. [Q8WWR8-3]
DR   RefSeq; NP_001161072.1; NM_001167600.2. [Q8WWR8-1]
DR   RefSeq; NP_001161073.1; NM_001167601.2. [Q8WWR8-1]
DR   RefSeq; NP_001161074.1; NM_001167602.2. [Q8WWR8-1]
DR   RefSeq; NP_542779.2; NM_080741.3. [Q8WWR8-2]
DR   UniGene; Hs.551747; -.
DR   ProteinModelPortal; Q8WWR8; -.
DR   SMR; Q8WWR8; -.
DR   BioGrid; 126209; 18.
DR   IntAct; Q8WWR8; 11.
DR   MINT; MINT-1447950; -.
DR   STRING; 9606.ENSP00000320318; -.
DR   BindingDB; Q8WWR8; -.
DR   ChEMBL; CHEMBL4174; -.
DR   SwissLipids; SLP:000001400; -. [Q8WWR8-2]
DR   SwissLipids; SLP:000001401; -. [Q8WWR8-1]
DR   CAZy; GH33; Glycoside Hydrolase Family 33.
DR   iPTMnet; Q8WWR8; -.
DR   PhosphoSitePlus; Q8WWR8; -.
DR   BioMuta; NEU4; -.
DR   DMDM; 90110434; -.
DR   PaxDb; Q8WWR8; -.
DR   PeptideAtlas; Q8WWR8; -.
DR   PRIDE; Q8WWR8; -.
DR   DNASU; 129807; -.
DR   Ensembl; ENST00000325935; ENSP00000320318; ENSG00000204099. [Q8WWR8-3]
DR   Ensembl; ENST00000391969; ENSP00000375830; ENSG00000204099. [Q8WWR8-1]
DR   Ensembl; ENST00000404257; ENSP00000385149; ENSG00000204099. [Q8WWR8-2]
DR   Ensembl; ENST00000405370; ENSP00000384804; ENSG00000204099. [Q8WWR8-1]
DR   Ensembl; ENST00000407683; ENSP00000385402; ENSG00000204099. [Q8WWR8-1]
DR   Ensembl; ENST00000616490; ENSP00000482722; ENSG00000277926. [Q8WWR8-2]
DR   Ensembl; ENST00000618866; ENSP00000483726; ENSG00000277926. [Q8WWR8-1]
DR   Ensembl; ENST00000621851; ENSP00000478409; ENSG00000277926. [Q8WWR8-1]
DR   Ensembl; ENST00000626600; ENSP00000485701; ENSG00000277926. [Q8WWR8-3]
DR   Ensembl; ENST00000630923; ENSP00000486602; ENSG00000277926. [Q8WWR8-1]
DR   GeneID; 129807; -.
DR   KEGG; hsa:129807; -.
DR   UCSC; uc002wcm.4; human. [Q8WWR8-1]
DR   CTD; 129807; -.
DR   GeneCards; NEU4; -.
DR   HGNC; HGNC:21328; NEU4.
DR   HPA; HPA037394; -.
DR   HPA; HPA037395; -.
DR   MIM; 608527; gene.
DR   neXtProt; NX_Q8WWR8; -.
DR   OpenTargets; ENSG00000204099; -.
DR   PharmGKB; PA134917116; -.
DR   eggNOG; ENOG410IFVF; Eukaryota.
DR   eggNOG; ENOG410Y74Z; LUCA.
DR   GeneTree; ENSGT00390000011171; -.
DR   HOGENOM; HOG000233778; -.
DR   HOVERGEN; HBG052608; -.
DR   InParanoid; Q8WWR8; -.
DR   KO; K12357; -.
DR   OMA; HIDCKEC; -.
DR   OrthoDB; EOG091G08BI; -.
DR   PhylomeDB; Q8WWR8; -.
DR   TreeFam; TF331063; -.
DR   BRENDA; 3.2.1.18; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   Reactome; R-HSA-4085001; Sialic acid metabolism.
DR   SABIO-RK; Q8WWR8; -.
DR   GeneWiki; NEU4; -.
DR   GenomeRNAi; 129807; -.
DR   PRO; PR:Q8WWR8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000204099; -.
DR   CleanEx; HS_NEU4; -.
DR   ExpressionAtlas; Q8WWR8; baseline and differential.
DR   Genevisible; Q8WWR8; HS.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0019866; C:organelle inner membrane; IDA:UniProtKB.
DR   GO; GO:0052794; F:exo-alpha-(2->3)-sialidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052795; F:exo-alpha-(2->6)-sialidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052796; F:exo-alpha-(2->8)-sialidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004308; F:exo-alpha-sialidase activity; IDA:UniProtKB.
DR   GO; GO:0006689; P:ganglioside catabolic process; IDA:UniProtKB.
DR   GO; GO:0006516; P:glycoprotein catabolic process; IDA:UniProtKB.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0009313; P:oligosaccharide catabolic process; IDA:UniProtKB.
DR   InterPro; IPR026946; Sialidase-4.
DR   InterPro; IPR026856; Sialidase_fam.
DR   InterPro; IPR011040; Sialidases.
DR   PANTHER; PTHR10628; PTHR10628; 1.
DR   PANTHER; PTHR10628:SF25; PTHR10628:SF25; 1.
DR   Pfam; PF13088; BNR_2; 1.
DR   SUPFAM; SSF50939; SSF50939; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Carbohydrate metabolism; Complete proteome;
KW   Glycosidase; Hydrolase; Lipid degradation; Lipid metabolism; Lysosome;
KW   Membrane; Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1    484       Sialidase-4.
FT                                /FTId=PRO_0000208906.
FT   REPEAT      127    138       BNR 1.
FT   REPEAT      200    211       BNR 2.
FT   REPEAT      251    262       BNR 3.
FT   MOTIF        22     25       FRIP motif.
FT   COMPBIAS    284    375       Pro-rich.
FT   ACT_SITE     47     47       Proton acceptor. {ECO:0000250}.
FT   ACT_SITE     48     48       Proton acceptor. {ECO:0000250}.
FT   ACT_SITE    419    419       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    440    440       {ECO:0000255}.
FT   BINDING      23     23       Substrate. {ECO:0000250}.
FT   BINDING      43     43       Substrate. {ECO:0000250}.
FT   BINDING     177    177       Substrate. {ECO:0000250}.
FT   BINDING     179    179       Substrate. {ECO:0000250}.
FT   BINDING     222    222       Substrate. {ECO:0000250}.
FT   BINDING     242    242       Substrate. {ECO:0000250}.
FT   BINDING     389    389       Substrate. {ECO:0000250}.
FT   VAR_SEQ       1      1       M -> MMSSAAFPRWLSM (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037491.
FT   VAR_SEQ       1      1       M -> MMSSAAFPRWLQSM (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_047123.
FT   VARIANT     301    301       G -> R (in dbSNP:rs11545301).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:14962670,
FT                                ECO:0000269|PubMed:15498874}.
FT                                /FTId=VAR_067458.
FT   CONFLICT    184    184       R -> L (in Ref. 1; CAC81904).
FT                                {ECO:0000305}.
SQ   SEQUENCE   484 AA;  51572 MW;  14A878C2A9F18863 CRC64;
     MGVPRTPSRT VLFERERTGL TYRVPSLLPV PPGPTLLAFV EQRLSPDDSH AHRLVLRRGT
     LAGGSVRWGA LHVLGTAALA EHRSMNPCPV HDAGTGTVFL FFIAVLGHTP EAVQIATGRN
     AARLCCVASR DAGLSWGSAR DLTEEAIGGA VQDWATFAVG PGHGVQLPSG RLLVPAYTYR
     VDRRECFGKI CRTSPHSFAF YSDDHGRTWR CGGLVPNLRS GECQLAAVDG GQAGSFLYCN
     ARSPLGSRVQ ALSTDEGTSF LPAERVASLP ETAWGCQGSI VGFPAPAPNR PRDDSWSVGP
     GSPLQPPLLG PGVHEPPEEA AVDPRGGQVP GGPFSRLQPR GDGPRQPGPR PGVSGDVGSW
     TLALPMPFAA PPQSPTWLLY SHPVGRRARL HMGIRLSQSP LDPRSWTEPW VIYEGPSGYS
     DLASIGPAPE GGLVFACLYE SGARTSYDEI SFCTFSLREV LENVPASPKP PNLGDKPRGC
     CWPS
//
